Dld Asset Management, LP Vascular Biogenics Ltd. Call Options Transaction History

Dld Asset Management, LP

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	BUY	$1.22 - $1.95 $411,506 - $657,735	337,300 New	337,300 $541,000
Q2 2018 Aug 14, 2018	SELL	$2.05 - $3.0 $501,224 - $733,500	-244,500 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$2.27 - $8.5 $555,015 - $2.08 Million	244,500 New	244,500 $555,000

416K

Ticker VBLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,348,896
Description
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...

Get notified when there are updates to the investment portfolio of Dld Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Dld Asset Management, LP with notifications on news.